"New spray appears to treat premature ejaculation"
Source: CTV.CA
Published: 26 Apr 2022
Category: Pharmaceutical
Rating:
(1½ stars)
what they said (Hover the mouse cursor over underlined words for more info)
Men who suffer from the little-discussed problem of premature ejaculation might find a solution in an anesthetic spray.
Study results suggest the spray, which at the moment is called PSD502, is effective in helping men last longer during intercourse by temporarily reducing sensation in the skin...
The original article can be found at: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20090424/spray_090426/20090426?hub=Health
Criteria |
Rating |
Availability of Treatment |
Not Satisfactory (?) |
Novelty of Treatment |
Satisfactory (?) |
Disease Mongering |
Not Satisfactory (?) |
Treatment Options |
Satisfactory (?) |
Costs of Treatment |
Not Satisfactory (?) |
Evidence |
Satisfactory (?) |
Quantification of Benefits of Treatment |
Not Satisfactory (?) |
Harms of Treatment |
Not Satisfactory (?) |
Sources of Information |
Not Satisfactory (?) |
Relies on Press Release |
Not Applicable |
Quantification of Harms of Treatment |
Not Satisfactory (?) |
what we said (Hover the mouse cursor over underlined words for more info)
This is the type of story which is designed to get investors excited, and create a buzz in the community but has very little of substance to back it up. The results of a presentation at a scientific conference should not be considered adequate and worthy of coverage because people need to know these results are not peer reviewed. The main problem with the story lies in the discussion of both the condition (said to affect 20-30% of men) which seem based on exaggerated prevalence statistics, and the treatment, which is a lidocaine-prilocaine combination product, typically used in dentistry. This may be a novel use for an old drug, yet before we turn to medications like this one (still in the experimental phase) it is worth knowing what exactly is the condition "Premature Ejaculation" to start with.
public forum
There are currently no comments on this article.
|